Neal X Rosen

29PUBLICATIONS
244CO-AUTHORS
Molecular targetsHaematological tumoursNutrigenomics and personalised nutritionPredictive and prognostic markersBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 21, 2025
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.

Jacob A Boyer, Ezra Y Rosen, Malvika Sharma

|Apr 28, 2025
Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations.

Michelangelo Marasco, Dinesh Kumar, Santiago Garcia Borrego

|Feb 24, 2025
Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration.

Sunyana Gadal, Jacob A Boyer, Simon F Roy

|Jul 18, 2024
Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer.

Hidenori Kitai, Philip H Choi, Yu C Yang

|Jul 09, 2024
Diet induced insulin resistance is due to induction of PTEN expression.

Neal Rosen, Radha Mukherjee, Priya Pancholi

|Jun 26, 2024
Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets.

Monica F Chen, Soo-Ryum Yang, Jessica J Tao

Pageof 5

Frequent Collaborators

5 joint publications

Elisa de Stanchina

5 joint publications

Rona Yaeger

4 joint publications

Sarat Chandarlapaty

4 joint publications

David B Solit